Low level of HBV-DNA is the most powerful predictive factor of better response to IFN-α therapy in chronic hepatitis B K. Simon,A. Gładysz,M. Zalewska, K. Rotter, W. Dobracki,A. Głowacki,M. Inglot,B. Knysz,A. Machaj,P. PiszkoJournal of Hepatology（1998）引用 1|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
